This paper has studied and compared three methods of determination of cardiovascular drug, Nitrendipine: Cyanide selective electrode method, single sweep polarography and UV-spectrophotometric method.

None of the patients took the medicine for more than 12 weeks, and the trials offered no evidence that it had reduced heart attacks or cardiovascular disease, the goal of any cholesterol drug.

Cardiovascular risk needs to be taken into account when prescribing any non-steroidal anti-inflammatory drug.